Company news
Scancell Holdings Plc (LSE:SCLP) news
Scancell Holdings Plc news releases on 6ix. Latest, Jul 10, 2024: Appointment of Dr Florian Reinaud to the Board
Press releases — page 2
Appointment of Dr Florian Reinaud to the Board
July 10, 2024
Extension of Convertible Loan Notes
July 2, 2024
Block Listing Return and Total Voting Rights
July 1, 2024
Change of Nominated Advisor
June 21, 2024
Agreement with major biotech
June 12, 2024
Update on ModiFY trial
May 30, 2024
Scancell to present at ASCO Annual Meeting
May 24, 2024
Presenting at the Sachs 10th Annual Oncology Forum
May 16, 2024
Scancell presenting at 21st CIMT Annual Meeting
May 9, 2024
Presenting at the Annual Immuno-Oncology Summit
April 17, 2024
Block Listing Six Monthly Return
April 16, 2024
Employee exercise of share options
April 3, 2024
Scancell to Present at 2024 AACR Annual Meeting
April 2, 2024
Scancell Appoints WG as Joint Broker
March 28, 2024
First iSCIB1+ patient dosed
March 26, 2024
Appointment of Sath Nirmalananthan to the Board
March 14, 2024
Scancell Attendance at Upcoming Conferences
March 12, 2024
Presenting at Next-Gen Immuno-Oncology Conference
March 4, 2024
Change of Auditor
February 20, 2024
Directorate Change
February 5, 2024
Notice of Interim Results and Presentation
January 26, 2024
Update on SCOPE trial
January 17, 2024
Result of the Open Offer
December 19, 2023
PDMR Notification
December 6, 2023
Results of Placing
December 1, 2023
Proposed Capital Raise to raise approximately £6m
November 30, 2023
Scancell to present at 20th SMR Congress
November 10, 2023
Scancell to present at 38th Annual SITC meeting
November 1, 2023
Results for the Year Ended 30 April 2023
October 31, 2023
Update on Final Results
October 20, 2023
Scancell to speak at World Vaccine Congress Europe
October 18, 2023
Change of Date for Final Results
October 11, 2023
Notice of Final Results and Investor Presentation
October 3, 2023
Scancell to present three posters at ICI
September 14, 2023
Scancell Appoints Head of Business Development
September 7, 2023
Scancell Appoints Sath Nirmalananthan as CFO
August 29, 2023
Modi-1 trial open for expansion in CPI combination
July 31, 2023
Extension of exercise period for CEO share options
July 13, 2023
Pipeline strategy and business update
July 10, 2023
Scancell to Present Modi-1 Data at ASCO
June 2, 2023
Issue of share options to Non-Executive Directors
April 21, 2023
ModiFY Phase 1/2 poster presentation at AACR 2023
April 18, 2023
Block Listing Application to AIM
April 17, 2023
Statement re: Silicon Valley Bank (SVB)
March 13, 2023
Second Price Monitoring Extn
February 21, 2023
Price Monitoring Extension
February 21, 2023
Encouraging early efficacy data from ModiFY trial
February 21, 2023
Positive response in COVIDITY trial
February 13, 2023
Issue of Equity
February 8, 2023
Dr Jean-Michel Cosséry appointed as Chairman
February 1, 2023